Daniel F. I. Kurtycz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel F. I. Kurtycz has a total of 139 co-authors. Here are the top co-authors by number of shared publications:
- Guliz A. Barkan
Department of Pathology and Laboratory Medicine Loyola University Healthcare System Maywood Illinois USA
6 shared publications Z. Laura Tabatabai
University of California, San Francisco
5 shared publications- Marc Pusztaszeri
Department of Pathology, McGill University, Montreal, Quebec, Canada
4 shared publications - William C. Faquin
Department of Pathology Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA
4 shared publications Zubair Baloch
Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
4 shared publications- Christopher J. VandenBussche
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
3 shared publications
Latest Publications
- 22 May 2025
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 14 (6) , 384-394
American Society of Cytopathology (ASC) study group recommendations for practicing ultrasound guided-fine needle aspiration (US-FNA)
- 22 May 2025
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 14 (6) , 384-394
American Society of Cytopathology (ASC) study group recommendations for practicing ultrasound guided-fine needle aspiration (US-FNA)
- 15 April 2025
- Published by Elsevier in Journal of the American Society of Cytopathology
The International System for Reporting Serous Fluid Cytopathology survey data reveal substantial variability in the reporting and utilization of pelvic washing and peritoneal fluid specimens among pathologists and gynecologic oncologists
- 15 April 2025
- Published by Elsevier in Journal of the American Society of Cytopathology
The International System for Reporting Serous Fluid Cytopathology survey data reveal substantial variability in the reporting and utilization of pelvic washing and peritoneal fluid specimens among pathologists and gynecologic oncologists
- 6 December 2024
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 14 (2) , 110-122
The International System for Serous Fluid Cytopathology (TIS) survey in preparation for TIS 2.0
- 6 December 2024
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 14 (2) , 110-122
The International System for Serous Fluid Cytopathology (TIS) survey in preparation for TIS 2.0
- 17 November 2023
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 13 (1) , 67-77
Second edition of the Milan System for Reporting Salivary Gland Cytopathology: Refining the role of salivary gland FNA
- 17 November 2023
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 13 (1) , 67-77
Second edition of the Milan System for Reporting Salivary Gland Cytopathology: Refining the role of salivary gland FNA
- 16 November 2023
- Published by Wiley in Cancer Cytopathology
- Vol. 132 (1) , 10-21
Second edition of the Milan System for Reporting Salivary Gland Cytopathology: Refining the role of salivary gland FNA
The use of standardized reporting systems for non‐gynecologic cytopathology has made enormous gains in popularity during the past decade, including for thyroid fine‐needle aspiration, urine cytology, serous effusions, pancreas, lymph nodes, lung, and more. In February 2018, the first edition Atlas of the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was published. The MSRSGC defines six diagnostic fine‐needle aspiration categories encompassing the spectrum of non‐neoplastic, benign, and malignant lesions of the salivary glands. The goal of the MSRSGC is to combine each diagnostic category with a defined risk of malignancy and a specific clinical and/or surgical management algorithm. Since its initial publication in 2018, more than 200 studies and commentaries have been published confirming the role of the MSRSGC. The second edition of the MSRSGC, published in July 2023, includes refined risks of malignancy based on systematic reviews and meta‐analyses, a new chapter summarizing the use of salivary gland imaging, new advances in ancillary testing, and updates in nomenclature.
- 16 November 2023
- Published by Wiley in Cancer Cytopathology
- Vol. 132 (1) , 10-21
Second edition of the Milan System for Reporting Salivary Gland Cytopathology: Refining the role of salivary gland FNA
The use of standardized reporting systems for non‐gynecologic cytopathology has made enormous gains in popularity during the past decade, including for thyroid fine‐needle aspiration, urine cytology, serous effusions, pancreas, lymph nodes, lung, and more. In February 2018, the first edition Atlas of the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was published. The MSRSGC defines six diagnostic fine‐needle aspiration categories encompassing the spectrum of non‐neoplastic, benign, and malignant lesions of the salivary glands. The goal of the MSRSGC is to combine each diagnostic category with a defined risk of malignancy and a specific clinical and/or surgical management algorithm. Since its initial publication in 2018, more than 200 studies and commentaries have been published confirming the role of the MSRSGC. The second edition of the MSRSGC, published in July 2023, includes refined risks of malignancy based on systematic reviews and meta‐analyses, a new chapter summarizing the use of salivary gland imaging, new advances in ancillary testing, and updates in nomenclature.
- 16 November 2023
- Published by Wiley in Cytopathology
- Vol. 35 (2) , 188-198
Second edition of the Milan System for Reporting Salivary Gland Cytopathology: Refining the role of salivary gland FNA
The use of standardised reporting systems for non‐gynaecologic cytopathology has made enormous gains in popularity during the past decade, including for thyroid fine‐needle aspiration, urine cytology, serous effusions, pancreas, lymph nodes, lung and more. In February 2018, the first edition of the Atlas of the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was published. The MSRSGC defines six diagnostic fine‐needle aspiration categories encompassing the spectrum of non‐neoplastic, benign and malignant lesions of the salivary glands. The goal of the MSRSGC is to combine each diagnostic category with a defined risk of malignancy and a specific clinical and/or surgical management algorithm. Since its initial publication in 2018, more than 200 studies and commentaries have been published, confirming the role of the MSRSGC. The second edition of the MSRSGC, published in July 2023, includes refined risks of malignancy based on systematic reviews and meta‐analyses, a new chapter summarising the use of salivary gland imaging, new advances in ancillary testing and updates in nomenclature.
- 16 November 2023
- Published by Wiley in Cytopathology
- Vol. 35 (2) , 188-198
Second edition of the Milan System for Reporting Salivary Gland Cytopathology: Refining the role of salivary gland FNA
The use of standardised reporting systems for non‐gynaecologic cytopathology has made enormous gains in popularity during the past decade, including for thyroid fine‐needle aspiration, urine cytology, serous effusions, pancreas, lymph nodes, lung and more. In February 2018, the first edition of the Atlas of the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was published. The MSRSGC defines six diagnostic fine‐needle aspiration categories encompassing the spectrum of non‐neoplastic, benign and malignant lesions of the salivary glands. The goal of the MSRSGC is to combine each diagnostic category with a defined risk of malignancy and a specific clinical and/or surgical management algorithm. Since its initial publication in 2018, more than 200 studies and commentaries have been published, confirming the role of the MSRSGC. The second edition of the MSRSGC, published in July 2023, includes refined risks of malignancy based on systematic reviews and meta‐analyses, a new chapter summarising the use of salivary gland imaging, new advances in ancillary testing and updates in nomenclature.
- 27 June 2023
- Published by Springer Nature
- p. 27-47
Non-Neoplastic
- 8 September 2022
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 12 (1) , 66-74
Perceptions of Paris: an international survey in preparation for The Paris System for Reporting Urinary Cytology 2.0 (TPS 2.0)
- 8 September 2022
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 12 (1) , 66-74
Perceptions of Paris: an international survey in preparation for The Paris System for Reporting Urinary Cytology 2.0 (TPS 2.0)
- 7 January 2022
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 11 (2) , 62-66
We’ll always have Paris The Paris System for Reporting Urinary Cytology 2022
- 7 January 2022
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 11 (2) , 62-66
We’ll always have Paris The Paris System for Reporting Urinary Cytology 2022